ClinicalTrials.gg
CompletedNCT06567275Updated Jul 2, 2025

Comparison Between Serratus Anterior Plane Block and Erector Spinae Plane Block in Coarctectomy

An interventional study of Erector Spinae Plane Block and Serratus Anterior Plane Block in Aortic Coarctation, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 3 Months to 2 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-02.

Sponsored by Cairo University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
3 Months to 2 Years
Sex
All
01

Study summary

Pain is considered to be subjective, however, in children, it is believed to be felt rather than expressed because they often depend on the caregiver for their safety and well-being.

There is significant pain after thoracotomy surgery because of pleural and muscular damage, ribcage disruption, and intercostal nerve damage during surgery, which if not effectively managed, will lead to various systemic complications; pulmonary (atelectasis, pneumonia, and stasis of bronchial secretions), cardiovascular (increased oxygen consumption and tachycardia), musculoskeletal (muscle weakness), increased neurohormonal response and prolonged hospital stay. So adequate and sufficient post-operative analgesia for pediatric patients is mandatory.

The use of highly potent opioids for pediatric cardiothoracic anesthesia has gained widespread popularity during the last 20 years. In addition to the important advantage of hemodynamic stability, the large-dose opioid-based anesthetic techniques also blunt the stress response, However, large doses can cause oversedation, respiratory depression, and prolonged mechanical ventilation after surgery.

serratus anterior plane block guided by ultrasound was developed by Blanco et al, it is a novel technique in the management of pain following thoracic procedures.

Local anesthetic inserted into these planes will spread throughout the lateral chest wall, resulting in paresthesia of the T2 through T9 dermatomes of the anterolateral thorax. It became popular because it is much safer and easily administered than other alternative regional techniques such as thoracic paravertebral and thoracic epidural blocks.

The Erector Spinae Plane Block (ESPB) is also one of the recently known pain-controlling techniques used in pediatric cardiothoracic surgeries. It became popular because it is much safer and easily administered than other alternative regional techniques such as thoracic paravertebral and thoracic epidural blocks. Chin et al. documented the cadaveric spread of local anesthetic and noted that, radiologically, the local anesthetic spread extended 3 or 4 levels cranially and caudally from the site of injection.

These two blocks have been compared in a study by wang HJ et al in patients undergoing radical mastectomy.

To our knowledge, the comparison of serratus Plane Block versus erector spinae plane block in aortic coarctectomy operations in pediatric patients has not been investigated yet. This has encouraged the performance of the present study.

02

Conditions studied

  • Aortic Coarctation

Browse trials for

Keywords

  • erector spinae plane block
  • serratus anterior plane block
  • aortic coarctectomy
03

In context

Aortic Coarctation

49 studies on the registry are indexed under Aortic Coarctation; 16 are open to participants now.

This study's enrollment of 28 is below the median of 45 across 19 interventional studies indexed under Aortic Coarctation.

Browse Aortic Coarctation studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 2 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 3 months-2 years.
  • RACHS-1 score 3.
  • Patients undergoing aortic coarctectomy operation with Lateral thoracotomy incision.

Exclusion criteria

Exclusion Criteria:

  • Patients whose parents or legal guardians refuse to participate.
  • Preoperative mechanical ventilation.
  • Preoperative inotropic drug infusion.
  • Perioperative cardiopulmonary arrested patients.
  • Patients undergoing aortic coarctectomy operation with midline sternotomy incision.
  • History of mental retardation or delayed development that may interfere with pain intensity assessment.
  • Known or suspected coagulopathy. (PT \< 75% of control)
  • Any congenital anomalies or any infection at the site of injection.
  • Known or suspected allergy to any of the studied drugs.
  • liver enzymes elevated more than the normal values.
  • Renal function impairment (Creatinine value more than 1.2mg/dl or BUN more than 20mg/dl).
  • Heart failure patients
  • Redo patients and previous catheter dilatations
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    erector spinae plane block

    Ultrasound-guided erector spinae plane block will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%).

    Procedure: Erector Spinae Plane Block

  • Experimental
    serratus anterior plane block

    Ultrasound-guided serratus anterior plane block will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%).

    Procedure: Serratus Anterior Plane Block

Interventions

  • ProcedureErector Spinae Plane Block

    Ultrasound-guided erector spinae plane block will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%)

  • ProcedureSerratus Anterior Plane Block

    Ultrasound-guided serratus anterior plane block will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%)

06

What researchers measure

Primary outcomes

  1. Total intraoperative fentanyl consumption by mcg/kg.

    calculating the total dose of fentanyl used intraoperatively

    Time frame: Intra-operatively up to extubation

Secondary outcomes

  1. Time (in minutes) to 1st rescue analgesia (morphine)

    estimating the time of the need for 1st dose of morphine which was given for pain scores ≥ 4

    Time frame: 1st 24 hours postoperatively

  2. Heart rate and systolic blood pressure

    recorded at 5 minutes after intubation (baseline value), before skin incision at 15 minutes after the block, after skin incision, after rib retraction, after aortic clamping, after aortic declamping, immediately after skin closure, and at 15 minutes after extubation

    Time frame: up to 15 minutes after extubation

  3. The need and the dose of sodium nitroprusside after aortic clamping

    sodium nitroprusside was given to control the hypertensive response to aortic clamping

    Time frame: from aortic clamping until removal of the clamps

  4. total morphine dose

    morphine was given for pain scores ≥ 4

    Time frame: up to 24 hours after surgery

  5. Face, Legs, Activity, Cry, Consolability (FLACC) score

    Postoperative pain was assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) score every 2 hours for the first 24 hours postoperatively. If the FLACC score ≥ 4, 0.02 mg/kg morphine IV was administered as rescue analgesia to be repeated every 15-20 minutes till the pain score reaches \< 4, not exceeding 0.2 mg/kg every 6 hours

    Time frame: up to 24 hours after surgery

07

Study locations

1 site
  • Abu Elreish Hospital
    Cairo, Egypt
08

References and documents

Publications

  • Gado AAM, Atia MAM, Roman AA, Elsadeq WM, Jaccoub VF. Analgesic efficacy of ultrasound guided erector spinae plane block versus serratus anterior plane block in pediatric patients undergoing aortic coarctectomy; a randomized controlled study. BMC Anesthesiol. 2025 Jul 30;25(1):370. doi: 10.1186/s12871-025-03256-y. PubMed 40739624 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2024 to primary completion in Apr 2025, 7 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2024
First posted
Aug 22, 2024
StartActual
Aug 24, 2024
Primary completionActual
Apr 15, 2025
CompletionActual
Apr 15, 2025
Last update
Jul 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06567275
Lead sponsor
Cairo University
Responsible party
Ahmed Awad Eissa Roman (Principle investigator, Cairo University) — Principal investigator
First posted
Aug 22, 2024
Start date
Aug 24, 2024
Primary completion
Apr 15, 2025
Completion
Apr 15, 2025
Last update
Jul 2, 2025

Study contacts

Wafaa M Elsadeq
study director · Professor of Anesthesia, Pain Management, and Surgical ICU Faculty

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion